Headache Drugs Logo
Search    
Home | About Dr. Robbins | Archived Articles | Headache Books | Topic Index  


Back to List

Title:
Author:
Date:
Source:

Sumatriptan
     


  • Triptans: Actions and Reactions (June 2008)
  • Patient-Assessed Neck Tenderness Predicts Migraine Response to Triptans (June 2007)
  • Subcutaneous Sumatriptan for Refractory Trigeminal Neuralgia (May 2006)
  • Treatment of Cluster Headache Attacks with Less Than 6 mg. Subcutaneous Sumatriptan (November 2005)
  • Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine (October 2005)
  • Pilot Study Evaluating Preference for 3 mg. vs. 6 mg. Subcutaneous Sumatriptan (June 2005)
  • Early Treatment of a Migraine Attack while Pain is Still Mild Increases the Efficacy of Sumatriptan (January 2005)
  • Sumatriptan 50 mg. Consistently Relieves Migraine with "Sinus" Symptoms over Multiple Attacks (July 2003)
  • Sumatriptan: Economic Evidence for its use in the Treatment of Migraine, the Canadian Comparative Economic Analysis (January 2003)
  • Evidence-based Assessment of Pregnancy Outcome After Sumatriptan Exposure (December 2002)
  • Cost-effectiveness and Cost-benefit of Sumatriptan in Patients with Migraine (October 2002)
  • Mixing Sumatriptan (July 2002)
  • Sumatriptan Nasal Spray and Cognitive Function During Migraine: Results of an Open-Label Study (June 2001)
  • Cost Benefit Analysis of Sumatriptan Tablets Versus Usual Therapy for the Treatment of Migraine (July 2000)
  • Sumatriptan tablets are effective for migraine attacks with onset at any time: morning, day, evening and night (May 2000)
  • Sumatriptan Subcutaneous Injection for the Treatment of Morning Migraine: Results from the Sumatriptan Naratriptan Aggregate Patient (SNAP) Database (August 2002)
  • Sumatriptan Nasal Spray and Cognitive Function During Migraine: Results of an Open-Label Study (June 2001)